Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1986; 55(02): 293
DOI: 10.1055/s-0038-1661540
DOI: 10.1055/s-0038-1661540
Letter to the Editor
Effect of Injection of C1 Inactivator on the Platelet Count and Blood Coagulation in Rabbits Infused with Endotoxin
Further Information
Publication History
Received 05 August 1985
Accepted 16 December 1985
Publication Date:
18 July 2018 (online)
-
References
- 1 Osterud B, Bjorklid E. Human factor VII associated with endotoxin stimulated monocytes in whole blood. Biochem Biophys Res Commun 1982; 108: 620-626
- 2 Colucci M, Balconi G, Lorenzet R, Pietra A, Donati A MB, Semeraro N. Evidence that cultured human endothelial cells (EC) generate tissue factor in response to endotoxin. Thromb Haemostas 1983; 50: 253 (Abstr)
- 3 Brox JH, Osterud B, Bjorklid E, Fenton JW. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Brit J Haematol 1984; 57: 239-246
- 4 Morrison DC, Cochrane CG. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J Exp Med 1974; 140: 797-811
- 5 Nagayama M, Zucker MB, Beller F. Effects of a variety of endotoxins on human and rabbit platelet function. Thrombos Diathes Haemorrh 1971; 26: 467-473
- 6 Kane MA, May JE, Frank MM. Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation. J Clin Investig 1973; 52: 370-376
- 7 Triantaphyllopoulos DC. Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb Haemostas 1984; 51: 232-235
- 8 Everett MM, Emerson TE. Antithrombin III (AT III) increases survival tim e and diseases mortality during endotoxin shock in the rat. Cicul Shock 1984 13. Abst 29
- 9 Pixley RA, Schapira M, Colman RW. The regulation of human factor Xlla by plasma proteinase inhibitors. J Biol Chem 1985; 260: 1723-1729
- 10 Sim RB, Reboul A, Arlaud GJ, Villiers CL, Colomb MG. Interaction of 125I-labelled complement subcomponents Clr and Cls with protease inhibitors in plasma. FEBS Lett 1979; 97: 111-115
- 11 Ziccardi RJ. Activation of the early components of the classical component pathway under physiologic conditions. J Immunol 1981; 126: 1769-1773
- 12 Gallimore MJ, Amundsen E, Larsbraaten M, Lyngaas K, Fareid E. Studies on plasma inhibitors of plasma kallikrein using chromogenic substrate assays. Thromb Res 1979; 16: 695-703
- 13 Forbes CD, Pensky J, Ratnoff OD. Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified Cl inactivator. J Lab Clin Med 1970; 76: 809-815
- 14 Wickerhauser M, Hao Y L, Mercer J. Method for large scale preparation of Cl inhibitor concentrate for clinical studies (Abstr). Joint Congress of the International Societies of Hematology and Blood Transfusion Paris: 1978
- 15 Lennick M, Brew SA, Ingham KC. Changes in protein configuration and stability accompanying complex formation between Cl inhibitor and Cls. Biochem 1985; 24: 2561-2568